SANDOSTATIN LAR FOR INJECTION 30 mg
Product details
Registration number: SIN11638P
Classification: Prescription Only
Active ingredients: OCTREOTIDE ACETATE 33.6MG EQV OCTREOTIDE
Strength: 30 mg/vial
Dosage form: INJECTION
Route: INTRAMUSCULAR
Registrant: NOVARTIS (SINGAPORE) PTE LTD
ATC code: H01CB02
HSA approval date: 20 August 2001
Manufacturer(s):
- Novartis Pharmaceutical Manufacturing GmbH
- Abbott Biologicals B.V. (Vehicle solution)
Manufacturing country/countries: AUSTRIA; NETHERLANDS
What are the HSA registration number and classification for SANDOSTATIN LAR FOR INJECTION 30 mg?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN11638P
Classification: Prescription Only
What active ingredients and strength are recorded for SANDOSTATIN LAR FOR INJECTION 30 mg?
According to the HSA dataset updated 7 August 2026:
Active ingredients: OCTREOTIDE ACETATE 33.6MG EQV OCTREOTIDE
Strength: 30 mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for SANDOSTATIN LAR FOR INJECTION 30 mg?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION
Route: INTRAMUSCULAR
Who is the recorded registrant for SANDOSTATIN LAR FOR INJECTION 30 mg?
According to the HSA dataset updated 7 August 2026:
Registrant: NOVARTIS (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for SANDOSTATIN LAR FOR INJECTION 30 mg?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Novartis Pharmaceutical Manufacturing GmbH
- Abbott Biologicals B.V. (Vehicle solution)
Manufacturing country/countries: AUSTRIA; NETHERLANDS
Where can I look up SANDOSTATIN LAR FOR INJECTION 30 mg in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN11638P or the exact product name SANDOSTATIN LAR FOR INJECTION 30 mg. The general register link does not preselect this product.
What are the source dates for this SANDOSTATIN LAR FOR INJECTION 30 mg record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this SANDOSTATIN LAR FOR INJECTION 30 mg record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN11638P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)